AKRX

Akorn (AKRX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AKRX
DataOraFonteTitoloSimboloCompagnia
26/05/202022:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKRXAkorn Inc
21/05/202005:52PR Newswire (US)Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term SuccessNASDAQ:AKRXAkorn Inc
11/05/202023:14GlobeNewswire Inc.Akorn Provides First Quarter 2020 ResultsNASDAQ:AKRXAkorn Inc
11/05/202022:56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AKRXAkorn Inc
08/05/202017:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKRXAkorn Inc
28/04/202000:17PR Newswire (US)Enphase Energy and Paylocity Set to Join S&P MidCap 400; Core Laboratories and Meredith to Join S&P SmallCap 600NASDAQ:AKRXAkorn Inc
24/04/202023:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKRXAkorn Inc
21/04/202012:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AKRXAkorn Inc
10/04/202023:08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AKRXAkorn Inc
01/04/202023:08Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:AKRXAkorn Inc
01/04/202012:20PR Newswire (US)Akorn Provides Update on Sale ProcessNASDAQ:AKRXAkorn Inc
18/03/202016:40Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:AKRXAkorn Inc
16/03/202021:11Edgar (US Regulatory)Amended Application for Qualification of Trust Indentures (t-3/a)NASDAQ:AKRXAkorn Inc
13/03/202021:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKRXAkorn Inc
26/02/202022:58GlobeNewswire Inc.Akorn Provides Fourth Quarter and Full Year 2019 ResultsNASDAQ:AKRXAkorn Inc
26/02/202022:51Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AKRXAkorn Inc
12/02/202023:29PR Newswire (US)Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its BusinessNASDAQ:AKRXAkorn Inc
10/02/202013:00PR Newswire (US)Akorn Continues Negotiations with LendersNASDAQ:AKRXAkorn Inc
16/12/201913:51GlobeNewswire Inc.Akorn Announces Extension of Standstill AgreementNASDAQ:AKRXAkorn Inc
06/11/201901:00GlobeNewswire Inc.Akorn to Present at the Credit Suisse Healthcare ConferenceNASDAQ:AKRXAkorn Inc
31/10/201912:00GlobeNewswire Inc.Akorn Provides Preliminary Third Quarter 2019 ResultsNASDAQ:AKRXAkorn Inc
14/10/201922:25GlobeNewswire Inc.Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%NASDAQ:AKRXAkorn Inc
14/10/201919:05GlobeNewswire Inc.Akorn to Report Third Quarter 2019 Financial Results and Host Conference CallNASDAQ:AKRXAkorn Inc
26/08/201922:10Edgar (US Regulatory)Application for Qualification of Trust Indentures (t-3)NASDAQ:AKRXAkorn Inc
26/08/201919:35GlobeNewswire Inc.Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%NASDAQ:AKRXAkorn Inc
02/08/201919:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AKRXAkorn Inc
01/08/201913:00GlobeNewswire Inc.Akorn Provides Preliminary Second Quarter 2019 ResultsNASDAQ:AKRXAkorn Inc
19/07/201923:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AKRXAkorn Inc
11/07/201922:32GlobeNewswire Inc.Akorn to Report Second Quarter 2019 Financial Results and Host Conference CallNASDAQ:AKRXAkorn Inc
28/06/201913:00GlobeNewswire Inc.Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%NASDAQ:AKRXAkorn Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AKRX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network